5-Amino-1MQ
Small-molecule NNMT inhibitor for adipose and metabolic research
5 mg vial · 50 mg vialpeptide
A modified fragment of human growth hormone studied in lipid-metabolism models.
AOD-9604 · 10 mg · Lyophilised vial
peptide
A modified fragment of human growth hormone studied in lipid-metabolism models.
In stock
AOD-9604 is a synthetic peptide corresponding to the C-terminal region of human growth hormone (residues 176 to 191) with an added N-terminal tyrosine. It was designed to retain the lipolytic region of the parent hormone without its growth-promoting activity.
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
| Compound | AOD-9604 |
|---|---|
| Type | Peptide |
| Selected presentation | 10 mg · Lyophilised vial |
| Form | Lyophilised powder in a sealed glass vial |
| Fill volume and concentration | Not applicable (lyophilised) |
| Label | CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only" |
| Storage | -20 °C for long-term storage; 2 to 8 °C for under three months; away from light |
| Certificate of analysis | Not yet published online. Request for a batch |
| Research areas | Metabolic & GLP research |
| All presentations | 10 mg lyophilised vial · € 55.00 |